About Be-Line Pharmaceuticals Private Limited
Data last updated:
Be-Line Pharmaceuticals Private Limited is a private limited company based in Thanjavur, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 December 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1994PTC029511. Its GSTIN is 33AAACB8049F1ZX (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.53 Lakh. It is led by directors including Karunai Kadal Valliammai (Managing Director) and Sudharaman Sunilkumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.3306/66 Shanthi Nagar Nk Road, Thanjavur, Tamil Nadu, India – 613006.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.16 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹4.81 Lakh (net margin 2.2%) and EBITDA of ₹7.09 Lakh (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
The company is associated with 1 brand: Be-line pharmaceuticals. As per MCA filings, the company has open charges of ₹68 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website belinepharma.com.
Company details
Contact details
Be-Line Pharmaceuticals Private Limited's registered office is in Thanjavur, Tamil Nadu. Its website is belinepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.3306/66 Shanthi Nagar Nk Road, Thanjavur, Tamil Nadu, India – 613006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Be-Line Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Be-Line Pharmaceuticals operates one associated brand: Be-line pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical syrups, pills, antibiotics, and health supplements for consumers and doctors. | belinepharma.com |
Business activity
The main business activity of Be-Line Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Be-Line Pharmaceuticals Private Limited, buy the company report.
Financials of Be-Line Pharmaceuticals Private Limited
FY 2025 filings availableBe-Line Pharmaceuticals Private Limited reported revenue of ₹2.16 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 9% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Be-Line Pharmaceuticals Private Limited, buy the company report.
Board of directors of Be-Line Pharmaceuticals Private Limited
Be-Line Pharmaceuticals has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudharaman Sunilkumar | Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Karunai Kadal | Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Mohamed Farook | Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Janardhanan | Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Sarah Ramkumar | Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Mohamed Kamaludeen Banufarook | Director | 14 Aug 1995 | 31 Years 2 Months | Current |
Peer comparison
Be-Line Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jiwadaya Healthcare Private Limited | ₹2.17 Cr (FY 2025) | -15.0% | Mumbai, Maharashtra, India | |||
| Saanvi Pharmachem Private Limited | ₹2.16 Cr (FY 2024) | 2.0% | Moradabad, Uttar Pradesh, India | |||
| Be-Line Pharmaceuticals Private Limitedthis company | ₹2.16 Cr (FY 2025) | ₹4.81 Lakh | 2.2% | -9.0% | Thanjavur, Tamil Nadu, India | |
| Sirius Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2024) | 86.0% | Mumbai, Maharashtra, India | |||
| Roulex Laboratories Private Limited | ₹2.15 Cr (FY 2025) | 50.0% | Ernakulam, Kerala, India |
To see the full peer comparison of Be-Line Pharmaceuticals Private Limited, buy the company report.
Auditor
Be-Line Pharmaceuticals Private Limited is audited by VRUKSHA AND CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VRUKSHA AND CO | FY 2022 | 007238S |
Shareholding
The shareholding of Be-Line Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Be-Line Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Oct 2021 | 100490775 | Vijaya Bank | ₹46 Lakh | Open | |
| 09 Mar 1998 | 90283815 | Vijaya Bank | ₹22 Lakh | Open |
To see the full charge records of Be-Line Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Be-Line Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Be-Line Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Be-Line Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACB8049F1ZX | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Be-Line Pharmaceuticals Private Limited, buy the company report.
Recent activity
Be-Line Pharmaceuticals Private Limited has 14 board changes on record since 1994: 8 appointments and 6 cessations. The latest: Mohamed Kamaludeen Banufarook ceased to be Director on 04 May 2021.
8 earlier events are in the company report.
Frequently asked questions
Be-Line Pharmaceuticals is an active private limited company based in Thanjavur, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 December 1994 (32+ years old) and is registered under CIN U24231TN1994PTC029511.
Be-Line Pharmaceuticals has 8 current directors:
- Karunai Kadal Valliammai - Managing Director
- Sudharaman Sunilkumar - Director
- Karunai Kadal - Director
- Mohamed Farook - Director
- Janardhanan - Director
- Sarah Ramkumar - Director
- Mohamed Kamaludeen Banufarook - Director
- Janardanan Sujatha - Director
The latest financial statements of Be-Line Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Be-Line Pharmaceuticals is 33AAACB8049F1ZX, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Be-Line Pharmaceuticals is U24231TN1994PTC029511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Be-Line Pharmaceuticals was incorporated on 13 December 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Be-Line Pharmaceuticals by revenue are Jiwadaya Healthcare Private Limited, Saanvi Pharmachem Private Limited, Sirius Pharmaceuticals Private Limited, Roulex Laboratories Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohamed Kamaludeen Banufarook ceased to be Director on 04 May 2021. Sudharaman Sunilkumar ceased to be Director on 04 May 2021. Janardanan Sujatha ceased to be Director on 15 Mar 2021. Be-Line Pharmaceuticals has 14 board changes on record in total.
Be-Line Pharmaceuticals can be reached through the website belinepharma.com. Its registered office is in Thanjavur, Tamil Nadu, India.
The registered office of Be-Line Pharmaceuticals is at No.330666 Shanthi Nagar Nk Road, Thanjavur, Tamil Nadu, India – 613006.
Be-Line Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
